Pharmaceutical Industry Rolls Back Dr. Speaker Fees
The pharmaceutical industry seems to be spending less on speaker fees, but it hasn’t stopped influencing doctors and other medical personnel.
GlaxoSmithKline To Quit Paying Doctors For Promotional Talks
The company will no longer hire doctors to promote its drugs and will stop tying drug rep pay to number of prescriptions written.
In a major departure from industry practice, GlaxoSmithKline, the sixth-largest global drug maker, announced Tuesday that it will no longer hire doctors to promote its drugs. The company also will stop tying
